MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L- aspartate-treated cells, permitting CAD gene amplification

Molecular and Cellular Biology

Volumn 18, Issue 1, 1998, Pages 536-545

  Chernova, Olga B ^a   Chernov, Michail V ^a   Ishizaka, Yukihito ^b   Agarwal, Munna L ^a   Stark, George R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID DERIVATIVE; ONCOPROTEIN; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELLULAR DISTRIBUTION; DNA DAMAGE; DRUG RESISTANCE; GENE AMPLIFICATION; GENE EXPRESSION; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0031973018     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.1.536     Document Type: Article

References (71)

1. Agarwal, M. L., A. Agarwal, W. R. Taylor, and G. R. Stark. 1995. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA 92:8493-8497.
2. Agarwal, M. L., O. B. Chernova, A. Agarwal, W. R. Taylor, Y. K. Sharma, and G. R. Stark. Unpublished data.
3. Alitalo, K., and M. Schwab. 1986. Oncogene amplification in tumor cells. Adv. Cancer Res. 47:235-281.
4. Amati, B., and H. Land. 1994. Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. Curr. Opin. Genet. Dev. 4:102-108.
5. Babiss, L. E., and J. M. Friedman. 1990. Regulation of N-myc gene expression: use of an adenovirus vector to demonstrate posttranscriptional control. Mol. Cell. Biol. 10:6700-6708.
6. Brondyk, W. H., F. A. Boeckman, and W. E. Fahl. 1991. N-myc oncogene enhances mitogenic responsiveness of diploid human fibroblasts to growth factors but fails to immortalize. Oncogene 6:1269-1276.
7. Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752.
8. Chernova, O. B., M. V. Chernov, M. L. Agarwal, W. R. Taylor, and G. R. Stark. 1995. The role of p53 in regulating genomic stability when DNA and RNA synthesis are inhibited. Trends Biochem. Sci. 20:431-434.
9. Cox, L. S., and D. P. Lane. 1995. Tumour suppressors, kinases and clamps: how p53 regulates the cell cycle in response to DNA damage. Bioessays 17:501-508.
10. Cross, S. M., C. A. Sanchez, C. A. Morgan, M. K. Schimke, S. Ramel, R. L. Idzerda, W. H. Raskind, and B. J. Reid. 1995. A p53-dependent mouse spindle checkpoint. Science 267:1353-1356.
11. Darzynkiewicz, Z., S. Bruno, G. Del-Bino, W. Gorcyzyca, M. A. Hotz, P. Lassota, and F. Traganos. 1992. Features of apoptotic cells measured by flow cytometry. Cytometry 13:795-808.
12. Denis, N., A. Kitzis, J. Kruh, F. Dautry, and D. Corcos. 1991. Stimulation of methotrexate resistance and dihydrofolate reductase gene amplification by c-myc. Oncogene 6:1453-1457.
13. DePinho, R. A., E. Legouy, L. B. Feldman, N. E. Kohl, G. D. Yancopolous, and F. W. Alt. 1986. Structure and expression of the murine N-myc gene. Proc. Natl. Acad. Sci. USA 83:1827-1831.
14. Dias, P., P. Kumar, H. B. Marsden, H. R. Gattamaneni, J. Heighway, and S. Kumar. 1990. N-myc gene is amplified in alveolar rhabdomyosarcomas (RMS) but not in embryonal RMS. Int. J. Cancer 45:593-596.
15. Di Leonardo, A., S. P. Linke, K. Clarkin, and G. M. Wahl. 1994. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8:2540-2551.
16. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
17. Evan, G. I., A. H. Wyllie, C. S. Gilbert, T. D. Littlewood, H. Land, M. Brooks, C. M. Waters, L. Z. Penn, and D. C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128.
18. Facchini, L. M., S. Chen, W. W. Marhin, J. N. Lear, and L. Z. Penn. 1997. The Myc negative autoregulation mechanism requires Myc-Max association and involves the c-myc P2 minimal promoter. Mol. Cell. Biol. 17:100-114.
19. Franza, B., Jr., K. Maruyama, J. I. Garrels, and H. E. Ruley. 1986. In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenes. Cell 44:409-418.
20. Grandori, C., and R. N. Eisenman. 1997. Myc target genes. Trends Biochem. Sci. 22:177-181.
21. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
22. Harrington, E. A., M. R. Bennett, A. Fanidi, and G. I. Evan. 1994. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 13:3286-3295.
23. Hermeking, H., and D. Eick. 1994. Mediation of c-Myc-induced apoptosis by p53. Science 265:2091-2093.
24. 1 arrest. Proc. Natl. Acad. Sci. USA 93:4827-4832.
25. Ingvarsson, S., C. Asker, Z. Wirschubsky, J. Szpirer, G. Levan, G. Klein, and J. Sumegi. 1987. Mapping of Lmyc and Nmyc to rat chromosomes 5 and 6. Somatic Cell Mol. Genet. 13:335-339.
26. Ishizaka, Y., C. M. Chernov, C. M. Burns, and G. R. Stark. 1995. p53-dependent growth arrest of REF52 cells containing newly amplified DNA. Proc. Natl. Acad. Sci. USA 92:3224-3228.
27. Kearsey, J. M., P. J. Coates, A. R. Prescott, E. Warbrick, and P. A. Hall. 1995. Gadd45 is a nuclear cell cycle regulated protein which interacts with p21Cip1. Oncogene 11:1675-1683.
28. Ko, L. J., and C. Prives. 1996. p53: puzzle and paradigm. Genes Dev. 10:1054-1072.
29. Komuro, H., Y. Hayashi, M. Kawamura, K. Hayashi, Y. Kaneko, S. Kamoshita, R. Hanada, K. Yamamoto, T. Hongo, M. Yamada, et al. 1993. Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas. Cancer Res. 53:5284-5288.
30. Lee, W. H., A. L. Murphree, and W. F. Benedict. 1984. Expression and amplification of the N-myc gene in primary retinoblastoma. Nature 309:458-460.
31. Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
32. Linke, S. P., K. C. Clarkin, A. DiLeonardo, A. Tsou, and G. M. Wahl. 1996. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev. 10:934-947.
33. Livingstone, L. R., A. White, J. Sprouse, E. Livanos, T. Jacks, and T. D. Tlsty. 1992. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923-935.
34. Mai, S., J. Hanley-Hyde, and M. Fluri. 1996. c-Myc overexpression associated DHFR gene amplification in hamster, rat, mouse and human cell lines. Oncogene 12:277-288.
35. Marhin, W. W., S. Chen, L. M. Facchini, A. J. Fornace, Jr., and L. Z. Penn. 1997. Myc represses the growth arrest gene gadd45. Oncogene 14:2825-2834.
36. Miyashita, T., M. Krajewska, H. G. Wang, H. K. Lin, D. A. Liebermann, B. Hoffman, and J. C. Reed. 1994. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799-1805.
37. Moll, U. M., M. LaQuaglia, J. Benard, and G. Riou. 1995. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc. Natl. Acad. Sci. USA 92:4407-4411.
38. 1 checkpoint after DNA damage. Mol. Cell. Biol. 16:1126-1137.
39. Morgenstern, J. P., and H. Land. 1990. A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. Nucleic Acids Res. 18:1068.
40. Owen-Schaub, L. B., W. Zhang, J. C. Cusack, L. S. Angelo, S. M. Santee, T. Fujiwara, J. A. Roth, A. B. Deisseroth, W.-W. Zhang, E. Kruzel, and R. Radinsky. 1995. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell. Biol. 15:3032-3040.
41. Packham, G., and J. L. Cleveland. 1995. c-Myc and apoptosis. Biochim. Biophys. Acta 1242:11-28.
42. Perry, M. E., M. Commane, and G. R. Stark. 1992. Simian virus 40 large tumor antigen alone or two cooperating oncogenes convert REF52 cells to a state permissive for gene amplification. Proc. Natl. Acad. Sci. USA 89:8112-8116.
43. Philipp, A., A. Schneider, I. Vasrik, K. Finke, Y. Xiong, D. Beach, K. Alitalo, and M. Eilers. 1994. Repression of cyclin D1: a novel function of MYC. Mol. Cell. Biol. 14:4032-4043.
44. Poupon, M.-F., K. A. Smith, O. B. Chemova, C. Gilbert, and G. R. Stark. 1996. Inefficient growth arrest in response to dNTP starvation stimulates gene amplification through bridge-breakage-fusion cycles. Mol. Biol. Cell 7:345-354.
45. Roy, B., J. Beamon, E. Balint, and D. Reisman. 1994. Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors. Mol. Cell. Biol. 14:7805-7815.
46. Sakamuro, D., V. Eviner, K. J. Elliott, L. Showe, E. White, and G. C. Prendergast. 1995. c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene 11:2411-2418.
47. Sambrook, J., E. F. Frisch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
48. Schimke, R. T. 1988. Gene amplification in cultured cells. J. Biol. Chem. 263:5989-5992.
49. Schwab, M., J. Ellison, M. Busch, W. Rosenau, H. E. Varmus, and J. M. Bishop. 1984. Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. Proc. Natl. Acad. Sci. USA 81:4940-4944.
50. Shigesada, K., G. R. Stark, J. A. Maley, L. A. Niswander, and J. N. Davidson. 1985. Construction of cDNA to the hamster CAD gene and its application toward defining the domain for aspartate transcarbamylase. Mol. Cell. Biol. 5:1735-1742.
51. Smith, K. A., O. B. Chernova, R. P. Groves, M. B. Stark, J. L. Martinez, J. N. Davidson, J. M. Trent, T. E. Patterson, A. Agarwal, P. Duncan, M. L. Agarwal, and G. R. Stark. 1997. Multiple mechanisms of N-phosphonacetyl-L-aspartate resistance in human cell lines: carbamyl-P-synthetase/aspartate transcarbamylase/dihydro-orotase gene amplification is frequent only when chromosome 2 is rearranged. Proc. Natl. Acad. Sci. USA 94:1816-1821.
52. Smith, K. A., M. B. Stark, P. A. Gorman, and G. R. Stark. 1992. Fusions near telomeres occur very early in the amplification of CAD genes in Syrian hamster cells. Proc. Natl. Acad. Sci. USA 89:5427-5431.
53. Smith, M. L., I.-T. Chen, Q. Zhan, I. Bae, C. Y. Chen, T. M. Gilmer, M. B. Kastan, P. M. O'Connor, and A. J. Fornace, Jr. 1994. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 266:1376-1380.
54. Spurr, N. K., and R. White. 1991. Report of the committee on the genetic constitution of chromosome 2. Cytogenet. Cell Genet. 58:142-169.
55. Stanton, L. W., R. Watt, and K. B. Marcu. 1983. Translocation, breakage and truncated transcripts of c-myc oncogene in murine plasmacytomas. Nature 303:401-406.
56. Stark, G. R. 1993. Regulation and mechanisms of mammalian gene amplification. Adv. Cancer Res. 61:87-113.
57. Stewart, N., G. G. Hicks, F. Paraskevas, and M. Mowat. 1995. Evidence for a second cell cycle block at G2/M by p53. Oncogene 10:109-115.
58. Takahashi, K., and K. Suzuki. 1994. DNA synthesis-associated nuclear exclusion of p53 in normal human breast epithelial cells in culture. Oncogene 9:183-188.
59. Taylor, W. R., M. L. Agarwal, A. Agarwal, D. W. Stacey, and G. R. Stark. p53 inhibits entry into mitosis when DNA synthesis is blocked. Submitted for publication.
60. Tevosian, S. G., H. H. Shih, K. G. Mendelson, K.-A. Sheppard, K. E. Paulson, and A. S. Yee. 1997. HBP1: a HMG box transcriptional repressor that is targeted by the retinoblastoma family. Genes Dev. 11:383-396.
61. Tishler, R. B., S. K. Calderwood, C. N. Coleman, and B. D. Price. 1993. Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res. 53:2212-2216.
62. Tlsty, T. D. 1990. Normal diploid human and rodent cells lack a detectable frequency of gene amplification. Proc. Natl. Acad. Sci. USA 87:3132-3136.
63. Toledo, F., G. Buttin, and M. Debatisse. 1993. The origin of chromosome rearrangements at early stages of AMPD2 gene amplification in Chinese hamster cells. Curr. Biol. 3:255-264.
64. Vogan, K., M. Bernstein, J. M. Leclerc, L. Brisson, J. Brossard, G. M. Brodeur, J. Pelletier, and P. Gros. 1993. Absence of p53 gene mutations in primary neuroblastomas. Cancer Res. 53:5269-5273.
65. Wagner, A. J., J. M. Kokontis, and N. Hay. 1994. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev. 8:2817-2830.
66. White, A. E., E. M. Livanos, and T. D. Tlsty. 1994. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev. 8:666-677.
67. Woodruff, K. A., J. D. Rosenblatt, T. B. Moore, R. H. Medzoyan, D. S. Pai, J. L. Noland, J. M. Yamashiro, and R. K. Wada. 1995. Cell type-specific activity of the N-myc promoter in human neuroblastoma cells is mediated by a downstream silencer. Oncogene 10:1335-1341.
68. Wright, J. A., H. S. Smith, F. M. Watt, M. C. Hancock, D. L. Hudson, and G. R. Stark. 1990. DNA amplification is rare in normal human cells. Proc. Natl. Acad. Sci. USA 87:1791-1795.
69. Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704.
70. Xu, L., Y. Meng, R. Wallen, and R. A. DePinho. 1995. Loss of transcriptional attenuation in N-myc is associated with progression towards a more malignant phenotype. Oncogene 11:1865-1872.
71. Yin, Y., M. A. Tainsky, F. Z. Bischoff, L. C. Strong, and G. M. Wahl. 1992. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70:937-948.